LEADER 01566oam  2200397 a 450 
001 9910697140603321
005 20230902161854.0
035   $a(CKB)5470000002385507
035   $a(OCoLC)607933580
035   $a(EXLCZ)995470000002385507
100   $a20100419d2010      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aMedicare Part D$b[electronic resource] $espending, beneficiary cost sharing, and cost-containment efforts for high-cost drugs eligible for a specialty tier : report to the Chairman, Subcommittee on Health, Committee on Ways and Means, House of Representatives
210  1$a[Washington, D.C.] :$cU.S. Govt. Accountability Office,$d[2010]
215   $a1 online resource (ii, 38 pages) $cillustrations
300   $aTitle from PDF title screen (GAO, viewed Apr. 19, 2010).
300   $a"January 2010."
300   $a"GAO-10-242."
320   $aIncludes bibliographical references.
517   $aMedicare Part D 
606   $aMedicare$xEconomic aspects$zUnited States
606   $aPharmaceutical services insurance$xEconomic aspects$zUnited States
615  0$aMedicare$xEconomic aspects
615  0$aPharmaceutical services insurance$xEconomic aspects
712 02$aUnited States.$bCongress.$bHouse.$bCommittee on Ways and Means.$bSubcommittee on Health.
801  0$bVVK
801  1$bVVK
801  2$bGPO
906   $aBOOK
912   $a9910697140603321
996   $aMedicare Part D$93173020
997   $aUNINA